Fernando Gomollón García-rekin lankidetzan egindako argitalpenak (10)

2019

  1. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results from the ENEIDA Registry

    Inflammatory Bowel Diseases, Vol. 25, Núm. 11, pp. 1862-1870

  2. Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386

  3. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease

    Therapeutic Advances in Gastroenterology, Vol. 12

  4. Increased risk of thiopurine-related adverse events in elderly patients with IBD

    Alimentary Pharmacology and Therapeutics, Vol. 50, Núm. 7, pp. 780-788

2011

  1. Clinical patterns and outcomes of ischaemic colitis: Results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)

    Scandinavian Journal of Gastroenterology, Vol. 46, Núm. 2, pp. 236-246

  2. Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response

    Journal of Clinical Gastroenterology, Vol. 45, Núm. 2, pp. 113-118

2008

  1. Recomendaciones de actuación en pacientes con enfermedad de Crohn que empiezan tratamiento con adalimumab: Una guía rápida

    Gastroenterologia y Hepatologia, Vol. 31, Núm. 10, pp. 693-697

2007

  1. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants

    American Journal of Gastroenterology, Vol. 102, Núm. 3, pp. 507-515

  2. Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: A prospective, open-label, multicentre trial

    Alimentary Pharmacology and Therapeutics, Vol. 25, Núm. 4, pp. 409-418

2006

  1. Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease

    Gastroenterologia y Hepatologia, Vol. 29, Núm. 2, pp. 85-92